Healthcare - Biotechnology - NASDAQ - US
$ 4.53
-3.41 %
$ 36.1 M
Market Cap
-1.52
P/E
BALANCE SHEET
52.3 M
ASSETS
39 M
LIABILITIES
13.4 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Clene Inc.
| Current Assets | 38.9 M |
| Cash & Short-Term Investments | 35 M |
| Receivables | 1.34 M |
| Other Current Assets | 2.51 M |
| Non-Current Assets | 13.5 M |
| Long-Term Investments | 0 |
| PP&E | 13.4 M |
| Other Non-Current Assets | 58 K |
| Current Liabilities | 25.3 M |
| Accounts Payable | 1.5 M |
| Short-Term Debt | 20.7 M |
| Other Current Liabilities | 3.12 M |
| Non-Current Liabilities | 13.6 M |
| Long-Term Debt | 12.1 M |
| Other Non-Current Liabilities | 1.57 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | ||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 28.8 | 18.3 | 50.3 | 59.3 | 8.8 | 0.7 | |
| Short Term Investments | 6.2 | 5.0 | 0 | 0 | 0 | 0 | |
| Receivables | 1.3 | 0.2 | 1.6 | 2.2 | 0 | 0 | |
| Inventory | 37 K | 43 K | 41 K | 0.2 | 28 K | 0 | |
| Other Current Assets | 2.5 | 5.6 | 2.6 | 1.4 | 0.7 | 46.7 K | |
| Total Current Assets | 38.9 | 29.2 | 54.6 | 63.0 | 9.5 | 0.8 | |
| PP&E | 13.4 | 15.2 | 8.4 | 5.3 | 5.4 | 4.5 | |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | |
| Long Term Investments | 0 | 58 K | 58 K | 0 | 0 | 46.4 | |
| Other Long Term Assets | 58 K | 0 | 0 | (0.3) | (5.4) | (4.5) | |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Assets | 52.3 | 44.5 | 63.1 | 68.2 | 14.9 | 47.2 | |
| LIABILITIES | |||||||
| Accounts Payable | 1.5 | 3.0 | 1.9 | 1.1 | 0.9 | 1.1 | |
| Short Term Debt | 20.7 | 7.5 | 1.0 | 0.8 | 0.3 | 3.1 | |
| Other Current Liabilities | 3.1 | 3.3 | 3.1 | 9.5 | 2.9 | 1.1 | |
| Total Current Liabilities | 25.3 | 13.9 | 6.0 | 11.7 | 4.3 | 0.2 | |
| Long Term Debt | 12.1 | 24.8 | 23.5 | 3.9 | 2.5 | 0.2 | |
| Deferred Tax Income | 0 | 0 | 0 | 0.3 | (1.8) | (0.2) | |
| Other Liabilities | 1.6 | 2.6 | 20.9 | 52.0 | 75.9 | 39.9 | |
| Total Liabilities | 39.0 | 41.3 | 50.5 | 67.9 | 82.7 | 42.2 | |
| EQUITY | |||||||
| Common Stock | 13 K | 7 K | 6 K | 6 K | 2 K | 199 | |
| Retained Earnings | (242.7) | (193.2) | (163.3) | (153.6) | (69.6) | 17 K | |
| Other Accumulative Comprehensive Income/Loss | 0.2 | 0.2 | 0.2 | 0.3 | 41 K | 27.2 K | |
| Total Equity | 13.4 | 3.2 | 12.6 | 0.3 | (67.8) | 5.0 | |
| Total Liabilities and Equity | 52.3 | 44.5 | 63.1 | 68.2 | 14.9 | 47.2 | |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 104.9 | 65.2 | 61.6 | 60.1 | 17.4 | 1.4 | 1.9 |